Griffin Deep Genomics Platform

When a disease is developing in the body, the affected cells die and shed into the bloodstream. Life-threatening diseases like cancer leave a unique combination of mutations in the DNA of these dead cells. By investigating every single copy of cell-free DNA in a blood sample, we can gain a uniquely deep and comprehensive insight into the body’s current health status.


  • AI & Machine Learning
  • Our clinical data pipeline continues to grow and provides us with valuable insights into early cancer detection patterns.
  • Quantgene’s technology uses a redesigned sequencing process.
  • The GRIFFIN CORE is a proprietary software infrastructure

Main Features

  • Combining Deep Genomic sequencing and AI to detect disease down to a single molecule.

Primary Audience

  • Clinicians, technologists, data scientists, and business innovators